Azole-fused pyridazin-3(2H)-one derivatives
US12370192B2 · kind B2 · utility
0Cited by
16References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 15, 2020 |
| Grant date | Jul 29, 2025 |
| Priority date | — |
| Expiry date | Nov 30, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compounds of Formula (1) and pharmaceutically acceptable salts thereof, wherein α, β, n, R4, R5, R6, R8, R9, R10, R11, X1, X2, X3 and X7 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula (1), to pharmaceutical compositions comprising them, and to their use for treating diseases, disorders, and conditions associated with GPR139.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.